Novel Coronavirus-19 (COVID-19) in the immunocompromised transplant recipient: #Flatteningthecurve

Am J Transplant. 2020 Jul;20(7):1765-1767. doi: 10.1111/ajt.15890. Epub 2020 Apr 12.

Abstract

Worldwide collaboration will be required to define viral pathogenesis, correlates of immunity, and biomarkers for progressive infection to optimize clinical care and to interrupt pandemic spread of SARS-CoV-2.

Keywords: antibiotic: antiviral; clinical decision-making; complication: infectious; cytokines/cytokine receptors; editorial/personal viewpoint; immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; organ transplantation in general.

Publication types

  • Editorial

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Clinical Trials as Topic
  • Communicable Disease Control
  • Coronavirus Infections / complications*
  • Coronavirus Infections / prevention & control*
  • Disease Susceptibility
  • Humans
  • Immunocompromised Host*
  • Organ Transplantation
  • Pandemics / prevention & control*
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / prevention & control*
  • SARS-CoV-2
  • Transplant Recipients*
  • Viral Load